These drugs work in our vasculature, says Stefan Trapp, Ph.D., professor of autonomic neuroscience and metabolic disease at University College London
Multiple studies have highlighted the glycemic, weight, and cardiac benefits of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP1-RA), treatment in patients with or without type 2 diabetes (T2D)
These products are explicitly not for human or animal use, nor for consumption in any form
[DOI] [PubMed] [Google Scholar] 242.Rubino D., Abrahamsson N., Davies M., Hesse D., Greenway F.L., Jensen C., Lingvay I., Mosenzon O., Rosenstock J., Rubio M.A., et al
Mounjaro is already licensed and available in the UK for suitable patients
Further, it showed cardioprotective actions in ischemia and reperfusion injury [3]